Monopar Therapeutics Inc.

MNPR ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $13.2M

Liabilities Breakdown FY2022

Total Liabilities: $3.1M